Activated T cell proliferation

Activated T cell proliferation refers to the rapid division and clonal expansion of naïve or memory T lymphocytes following their stimulation by antigen-presenting cells via the major histocompatibility complex–peptide complex and necessary co-stimulatory signals such as those provided through CD28 engagement. This proliferative burst is essential for mounting effective adaptive immune responses against infections and tumors but must be tightly regulated; dysregulation can lead either to immunodeficiency or autoimmunity. The underlying mechanisms involve upregulation of ribosome biogenesis for increased protein synthesis capacity,[2] changes in surface markers,[3] secretion of cytokines,[6] and engagement with various intracellular signaling cascades.[7] While many drugs modulate aspects of this response indirectly—for example through checkpoint inhibition or provision/blockade of growth factors—the term itself does not denote an individual druggable entity but rather summarizes one phase within broader immune system dynamics.

Other names

T cell clonal expansionProliferation of activated T cellsAntigen-driven T cell expansion

Drugs affecting this process act by: - Stimulating co-stimulatory pathways (e.g., anti-CD28 antibodies)[7] - Providing growth factors/cytokines such as IL‑2[7] - Blocking inhibitory checkpoints to enhance activation/proliferation (e.g., anti-PD‑1/PD-L1)[6] - Inhibiting signaling pathways required for activation/proliferation in autoimmune settings